Stories > AB-2100 Phase 1/2 Trial Initiated

AB-2100 Phase 1/2 Trial Initiated

AI-Powered Antigen Research Partnership

Adagene Advances Clinical Collaboration

Advanced Ovarian Cancer Treatment Breakt...

Affini-T Therapeutics at J.P. Morgan Hea...

Anocca Appoints Martin Welschof to Board...

Atara Biotherapeutics at Health Conferen...